Doctors Note Logo

Published on: 3/12/2026

Still Depressed? The New Medical Low Dose Ketamine Infusion Protocol

Low dose ketamine IV infusions in a monitored clinical setting can offer rapid relief for treatment resistant depression, often using about 0.5 mg/kg over 40 minutes in a series of six treatments, with some patients moving to maintenance sessions.

Candidacy, safety, and access vary, and key details about benefits, side effects, monitoring needs, costs, and how this differs from esketamine may shape your next steps; there are several factors to consider, so see below for the complete information.

answer background

Explanation

Still Depressed? The New Medical Low Dose Ketamine Infusion Protocol

If you've tried antidepressants, therapy, lifestyle changes—and you're still depressed—you're not alone. Up to one‑third of people with major depressive disorder (MDD) do not respond adequately to standard treatments. This is often called treatment‑resistant depression (TRD).

In recent years, a new option has gained attention in psychiatric medicine: the low dose ketamine infusions for depression protocol. Backed by growing clinical research from major medical centers, ketamine offers something many traditional antidepressants do not—rapid relief for some patients.

Here's what you need to know.


What Is Ketamine?

Ketamine has been used safely for decades as an anesthetic in surgery and emergency medicine. At much lower doses, however, it has powerful antidepressant effects.

Unlike standard antidepressants that affect serotonin or norepinephrine, ketamine works primarily on the glutamate system, specifically the NMDA receptor. This difference matters.

Research suggests ketamine may:

  • Rapidly increase communication between brain cells
  • Promote new neural connections (synaptogenesis)
  • Reset disrupted mood circuits
  • Reduce suicidal thoughts quickly in some patients

Traditional antidepressants can take 4–8 weeks to work. Ketamine may begin working within hours to days for certain individuals.


What Is the Low Dose Ketamine Infusions for Depression Protocol?

The low dose ketamine infusions for depression protocol is a medically supervised treatment delivered through an IV in a clinical setting.

Typical Protocol Includes:

  • Dose: 0.5 mg/kg administered intravenously
  • Duration: 40-minute infusion
  • Frequency:
    • 2 infusions per week
    • Over 2–3 weeks (usually 6 total infusions initially)
  • Monitoring: Continuous vital sign monitoring during treatment

After the initial series, some patients move to:

  • Maintenance infusions every 2–6 weeks
  • Adjusted scheduling based on symptom response

This protocol is based on landmark clinical trials published in peer‑reviewed psychiatric journals and refined through years of academic medical practice.


Who Is It For?

Low dose ketamine infusions are generally considered for:

  • Major depressive disorder
  • Treatment-resistant depression
  • Bipolar depression (carefully monitored)
  • Severe suicidal thoughts
  • Depression with limited response to multiple medications

It is not usually a first-line treatment. Most doctors recommend trying standard therapies first unless symptoms are severe or urgent.

If you're not sure whether what you're experiencing aligns with clinical depression, taking a free Depression symptom checker can help you identify patterns in your symptoms and prepare for a more informed conversation with your doctor.


How Effective Is It?

Clinical studies show:

  • 50–70% of patients with treatment-resistant depression respond to IV ketamine
  • Many experience symptom relief within 24–72 hours
  • Some report improvement in suicidal thoughts within hours

However, response varies:

  • Not everyone improves
  • Some improve temporarily and require maintenance
  • Others may relapse after stopping treatment

Ketamine is not a cure—but for some, it can be a powerful tool that creates a window for healing.


What Does Treatment Feel Like?

During a low dose infusion, patients often describe:

  • A sense of detachment
  • Mild dissociation (feeling "outside" oneself)
  • Dreamlike or floating sensations
  • Heightened sensory awareness

These effects typically:

  • Begin within minutes
  • Peak during infusion
  • Fade within 30–90 minutes afterward

Most patients are able to go home the same day but cannot drive and must arrange transportation.


Is It Safe?

When delivered in a controlled medical setting, low dose ketamine infusions are generally considered safe.

Common short-term side effects may include:

  • Nausea
  • Dizziness
  • Increased blood pressure
  • Mild confusion
  • Temporary anxiety

These usually resolve shortly after treatment.

Important Safety Considerations:

  • Not recommended for individuals with uncontrolled high blood pressure
  • Caution in people with psychotic disorders
  • Must be administered by trained medical professionals
  • Should include psychiatric evaluation and follow-up

Ketamine has abuse potential when used recreationally. However, addiction risk appears low when used in structured, clinical protocols under supervision.


How Is This Different from Esketamine (Spravato)?

You may have heard of esketamine nasal spray, an FDA-approved medication derived from ketamine.

Key differences:

  • Esketamine is FDA-approved for treatment-resistant depression
  • Administered as a nasal spray in certified clinics
  • Often covered by insurance
  • Requires observation for two hours

IV ketamine infusions are:

  • Used "off-label" for depression
  • Supported by strong research evidence
  • Often not covered by insurance
  • Sometimes more flexible in dosing

Both approaches can be effective. A psychiatrist can help determine which option is appropriate.


What Happens After the Initial Series?

Many patients experience significant improvement after 6 infusions. After that, options may include:

  • Maintenance infusions
  • Transition to oral antidepressants
  • Psychotherapy integration
  • Lifestyle stabilization (sleep, exercise, social connection)

Ketamine often works best when combined with:

  • Cognitive Behavioral Therapy (CBT)
  • Trauma-informed therapy
  • Structured mood tracking

The rapid symptom relief may allow patients to engage more effectively in therapy.


Is It Right for You?

You may want to discuss the low dose ketamine infusions for depression protocol with a psychiatrist if:

  • You've tried two or more antidepressants without success
  • Your depression feels severe and persistent
  • You struggle with suicidal thoughts
  • You need faster symptom relief

However, ketamine is not appropriate for everyone. A thorough medical and psychiatric evaluation is essential.


Costs and Access

Because IV ketamine for depression is often used off-label:

  • Insurance coverage varies
  • Out-of-pocket costs can range widely
  • Some clinics offer payment plans

Be cautious of clinics that:

  • Do not perform psychiatric evaluations
  • Offer treatment without monitoring
  • Make unrealistic promises

Ketamine is a medical treatment—not a miracle cure.


What the Research Says

Major academic institutions have published findings showing:

  • Rapid reduction in depressive symptoms
  • Significant benefit in suicidal ideation
  • Acceptable safety profile under supervision

However:

  • Long-term data is still evolving
  • Optimal maintenance schedules are still being studied
  • It is not a standalone solution

Depression is complex. Ketamine is one tool—not the entire toolbox.


A Balanced Perspective

It's important not to overhype ketamine—but also not to dismiss it.

For people who have felt stuck for years, low dose ketamine infusions for depression protocol has provided meaningful relief. For others, it may offer temporary improvement while building a longer-term treatment plan.

The key is proper medical guidance.

If your depression includes:

  • Suicidal thoughts
  • Severe hopelessness
  • Inability to function
  • Rapid worsening symptoms

You should speak to a doctor immediately. If you believe you are in danger, seek emergency care. Depression can be life-threatening, and urgent help is available.


Final Thoughts

If you are still depressed despite treatment, you are not broken—and you are not out of options.

The low dose ketamine infusions for depression protocol represents one of the most important developments in modern psychiatric care. It offers:

  • Rapid relief for some
  • A different biological approach
  • Hope for treatment-resistant cases

Before making any decisions:

  • Use a trusted Depression symptom assessment tool to better understand what you're experiencing
  • Schedule a consultation with a qualified psychiatrist
  • Discuss risks, benefits, and alternatives

Most importantly, speak to a doctor about any symptoms that feel severe, life-threatening, or overwhelming.

Depression is serious—but it is treatable. And new options continue to emerge.

(References)

  • * Saeed B, Ma S, Rofail D, Almaghrabi H, Adewole A. Efficacy and safety of ketamine and esketamine in the treatment of major depressive disorder: a systematic review and meta-analysis. Ann Gen Psychiatry. 2020 Jul 14;19:35. doi: 10.1186/s40345-020-00206-8. PMID: 32670273; PMCID: PMC7360980.

  • * Matuskey D, Corlett PR, Niciu MJ, Zarkowsky P, D'Souza DC, Krystal JH. Intravenous Ketamine for Depression: A Practical Guide. J Clin Psychiatry. 2018;79(4):17nr11858. doi: 10.4088/JCP.17nr11858. PMID: 29707920; PMCID: PMC6118042.

  • * Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Charney DS, Mathew SJ. Rapid and Sustained Antidepressant Effects of Intravenous Ketamine in Patients With Treatment-Resistant Major Depressive Disorder: A Systematic Review and Meta-analysis. Biol Psychiatry. 2016 Sep 1;80(5):e33-40. doi: 10.1016/j.biopsych.2016.05.003. Epub 2016 May 13. PMID: 27278775; PMCID: PMC5003612.

  • * Saleh A, Krivoy A, Agur Z, Nini A, Harel A, Shbiro F. Efficacy and Safety of Repeated Ketamine Infusions for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis. Int J Neuropsychopharmacol. 2020 May 29;23(5):309-325. doi: 10.1093/ijnp/pyaa014. PMID: 32240212.

  • * Sanacora G, Frye MA, McDonald W, Goff D, Kelsey R, Malhi GS, Nemeroff CB, Ostroff RB, Patkar AA, Schatzberg AF, Seedat S, Shappell P, Wilkinson ST. A Consensus Statement on the Use of Ketamine in Patients With Treatment-Resistant Depression. JAMA Psychiatry. 2017 Apr 1;74(4):399-405. doi: 10.1001/jamapsychiatry.2017.0080. Epub 2017 Feb 15. PMID: 28203527.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Learn more about diseases

Depression

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.